Hepatic Glycogen Storage Disease Type IX : Long‐Term Outcomes in the UK From 89 Patients
Authors:
- 23 July 2026
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 49 (4)
Abstract
Hepatic glycogen storage disease type IX (GSD IX) is due to a deficiency of phosphorylase kinase and is one of the most common types of GSD. We conducted a retrospective, observational cohort study on individuals with GSD IX from across the United Kingdom. We describe the natural history and long‐term outcomes for 89 individuals with GSD IX with a median age of 16.4 years (range 4 months to 73 years). This included 60 patients with IXα2, 12 with IXβ and 13 with IXγ2. We report 49 novel alleles in PHKA2, PHKB and PHKG2 . The median age at initial presentation was 2.5 years, with 82% ( n = 68) presenting with hepatomegaly and 46% ( n = 38) presenting with ketotic hypoglycaemia. Steatosis was reported in 71% ( n = 12) who had a liver biopsy. The mean Z‐score for height at initial presentation was −1.21, and this significantly improved over childhood. A spectrum of severity was seen in all subtypes, with some requiring more intensive dietary management after initial presentation and others requiring no formal dietary treatment at all. No patients developed adenomas or hepatocellular carcinomas, and 75% ( n = 33) of adults were on no dietary therapy. Individuals with IXγ2 had a more severe disease course and had significantly worse biochemistry at initial presentation compared to other subtypes. They were diagnosed at a younger age and required more intensive dietary management across the lifespan. We believe that GSD IXγ2 is an ideal target for novel therapies. We recommend regular monitoring and multidisciplinary input in all patients with GSD IX and encourage more formal assessment of protein intake with each review.Keywords
This publication has 27 references indexed in Scilit:
- PHKA2 variants expand the phenotype of phosphorylase B kinase deficiency to include patients with ketotic hypoglycemia onlyAmerican Journal of Medical Genetics Part A, 2021
- Genotypic and clinical analysis of 49 Chinese children with hepatic glycogen storage diseasesMolecular Genetics & Genomic Medicine, 2020
- Hepatic Glycogenoses Among Children—Clinical and Biochemical Characterization: Single-Center StudyJournal of Clinical and Experimental Hepatology, 2020
- Clinical and genetic characteristics of 17 Chinese patients with glycogen storage disease type IXaGene, 2017
- Normoglycemic Ketonemia as Biochemical Presentation in Ketotic Glycogen Storage Disease2015
- X-linked glycogen storage disease IXa manifested in a female carrier due to skewed X chromosome inactivationClinica Chimica Acta, 2013
- Common mutation in the PHKA2 gene with variable phenotype in patients with liver phosphorylase b kinase deficiencyMolecular Genetics and Metabolism, 2011
- Liver glycogen storage diseases due to phosphorylase system deficiencies: Diagnosis thanks to non invasive blood enzymatic and molecular studiesMolecular Genetics and Metabolism, 2011
- The Structure of Phosphorylase Kinase Holoenzyme at 9.9 Å Resolution and Location of the Catalytic Subunit and the Substrate Glycogen PhosphorylaseStructure, 2009
- Glycogen storage disease type IX: High variability in clinical phenotypeMolecular Genetics and Metabolism, 2007